Buscar
Mostrando ítems 1-10 de 295
Effect of nωnla, an inhibitor of No-synthase, on the release of tissue-plasminogem activator from rat aorta
(2003-12-01)
Alterations in the synthesis or enhanced inactivation of nitric oxide (NO) and increase in fibrin deposition in the vascular bed lead to an imbalance that can induced intravascular coagulation. NO is produced through ...
Effect of nωnla, an inhibitor of No-synthase, on the release of tissue-plasminogem activator from rat aorta
(2003-12-01)
Alterations in the synthesis or enhanced inactivation of nitric oxide (NO) and increase in fibrin deposition in the vascular bed lead to an imbalance that can induced intravascular coagulation. NO is produced through ...
The multifaceted role of plasminogen in inflammation
A fine-tuned activation and deactivation of proteases and their inhibitors are involved in the execution of the
inflammatory response. The zymogen/proenzyme plasminogen is converted to the serine protease plasmin, a ...
Plasminogen Activator System in Periodontal DiseaseSistema Activador del Plasminógeno en la Enfermedad Periodontal
(Universidad Nacional Mayor de San Marcos, Facultad de Odontología, 2012)
Peritoneal fibrinolytic activity in equines subjected to small colon enterotomy and treated with heparin
(2014)
Study rationale: Heparin is routinely administered postoperatively in abdominal surgery to prevent the formation of adhesions; however, there is no consensus in the literature indicating the effectiveness of such use. ...
Glycosaminoglycans affect the interaction of human plasma kallikrein with plasminogen, factor XII and inhibitors
(Associação Brasileira de Divulgação Científica, 2003-08-01)
Human plasma kallikrein, a serine proteinase, plays a key role in intrinsic blood clotting, in the kallikrein-kinin system, and in fibrinolysis. The proteolytic enzymes involved in these processes are usually controlled ...
PAI-1 inhibition by simvastatin as a positive adjuvant in cell therapy
(2019-02-01)
Cell therapy (CT) can be briefly described as the use of cells or cell components in the treatment of diseases. One of the main challenges in establishing new cell types for therapy is the low survival rates of homing ...